their treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneity
of classifications and lack of randomized controlled trials. Here, a dedicated task force provides a
consensus statement on the overall management of CSMs.
Research question: To determine the best overall management of CSMs, depending on their clinical presentation,
size, and evolution as well as patient characteristics.
Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December
2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.
Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highly
specialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinological
and radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeons
or neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.
Bibliographical notePublisher Copyright:
© 2022 The Authors
Copyright 2023 Elsevier B.V., All rights reserved.